Literature DB >> 21893417

Fibrosis of pulmonary vascular remodeling in carotid artery-jugular vein shunt pulmonary artery hypertension model of rats.

Mai Xiong1, Jian-Ping Yao, Zhong-Kai Wu, Bing Liao, Ying-Jie Liang, Xi Zhang, Zhi-Ping Wang.   

Abstract

OBJECTIVE: The aim of the present study was to observe the changes of hemodynamics, stereology in pulmonary vascular remodeling and messenger RNA (mRNA) expressions of transforming growth factor beta 1, and receptors in carotid artery-jugular vein (CA-JV) shunt pulmonary artery hypertension model of rats.
METHODS: Thirty-six Sprague-Dawley rats were randomized into three groups: CA-JV group, monocrotaline (MCT) administration group, and control group. Left CA-JV shunts were established in CA-JV group. Dorsal subcutaneous injections of MCT (60 mg kg(-1)) were received in MCT group. Ligations of left common carotid artery and external jugular vein were performed in control group. Right ventricular systolic pressure (RVSP) measurement, histological evaluation of the pulmonary tissue, and mRNA levels of transforming growth factor beta 1 (TGFß1), receptor 1 and receptor 2, were investigated after 6 weeks on MCT group, and after 12 weeks on both control and CA-JV groups.
RESULTS: Compared with control group, RVSP, percentage of fibrous tissue (F%) in pulmonary arterioles, mRNA levels of TGFß1, and receptors of CA-JVand MCT groups increased significantly. Severe hemodynamics change was found in MCT groups. On the other hand, CA-JV group demonstrated more obvious fibrogenesis and TGFß1 signals' upregulation in two pulmonary artery hypertension (PAH) models.
CONCLUSIONS: CA-JV shunt model of rats was a well-established PAH animal model simulating congenital heart disease with systemic-pulmonary shunt.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21893417      PMCID: PMC3241121          DOI: 10.1016/j.ejcts.2011.04.031

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  24 in total

1.  Observations on hypoxic pulmonary hypertension.

Authors:  W C BOAKE; R DALEY; I K McMILLAN
Journal:  Br Heart J       Date:  1959-01

Review 2.  Pathology of pulmonary hypertension.

Authors:  Norbert F Voelkel; Carlyne Cool
Journal:  Cardiol Clin       Date:  2004-08       Impact factor: 2.213

3.  Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal?

Authors:  Kurt R Stenmark; Ivan F McMurtry
Journal:  Circ Res       Date:  2005-07-22       Impact factor: 17.367

Review 4.  Pulmonary vascular remodeling.

Authors:  Doug Miniati
Journal:  Semin Pediatr Surg       Date:  2007-05       Impact factor: 2.754

Review 5.  Beyond Mitomycin: TGF-beta and wound healing.

Authors:  M Francesca Cordeiro
Journal:  Prog Retin Eye Res       Date:  2002-01       Impact factor: 21.198

6.  Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension.

Authors:  Stephen Wedgwood; Jennifer M Devol; Albert Grobe; Eileen Benavidez; Anthony Azakie; Jeffrey R Fineman; Stephen M Black
Journal:  Pediatr Res       Date:  2007-01       Impact factor: 3.756

Review 7.  Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.

Authors:  Kurt R Stenmark; Karen A Fagan; Maria G Frid
Journal:  Circ Res       Date:  2006-09-29       Impact factor: 17.367

8.  Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats.

Authors:  Xiaoli Zhang; Yeqing Cui; Li Fang; Fei Li
Journal:  Pancreas       Date:  2008-10       Impact factor: 3.327

Review 9.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

10.  Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1 dependent pathway in rats.

Authors:  Hsao-Hsun Hsu; Wen-Je Ko; Jo-Yu Hsu; Jin-Shing Chen; Yung-Chie Lee; I-Rue Lai; Chau-Fong Chen
Journal:  Respir Res       Date:  2009-05-02
View more
  4 in total

1.  Hemodynamics and right-ventricle functional characteristics of a swine carotid artery-jugular vein shunt model of pulmonary arterial hypertension: An 18-month experimental study.

Authors:  Ji Wu; Xiaoju Luo; Yuanyuan Huang; Yun He; Zhixian Li
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-16

2.  Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.

Authors:  Wei Zhuang; Guili Lian; Bangbang Huang; Apang Du; Genfa Xiao; Jin Gong; Changsheng Xu; Huajun Wang; Liangdi Xie
Journal:  Exp Biol Med (Maywood)       Date:  2018-08-12

3.  Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats.

Authors:  Jiang Xie; Dayi Hu; Lili Niu; Suping Qu; Shenghao Wang; Shuang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

4.  Characteristics of Pulmonary Vascular Remodeling in a Novel Model of Shunt-Associated Pulmonary Arterial Hypertension.

Authors:  Mingjie Zhang; Zhiyu Feng; Rui Huang; Chongrui Sun; Zhuoming Xu
Journal:  Med Sci Monit       Date:  2018-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.